EDGAR·FLOW

Oscar Health, Inc. — Form 8-K

Filed November 5, 2026 · analyzed by the 8-K Agent
8-K ▲ Likely positive significance 72/100
What the filing says
Oscar Health reported Q3 2026 net income of $167.3M ($0.49 diluted EPS) vs. $137.5M loss year-ago, driven by improved MLR (84.0% vs. 88.5%), disciplined pricing, and $250M favorable risk adjustment benefit. The company raised full-year 2026 earnings from operations guidance to $850M–$950M (from $600M–$800M), revenue to $19.0B–$19.3B (from $18.7B–$19.0B), and lowered MLR guidance to 80.5%–81.5%. Membership grew to 2.69M from 2.11M year-ago; nine-month net income was $1.21B vs. $90.5M loss.
Why this rating

Strong swing to profitability and third consecutive guidance raise materially improves earnings trajectory for ~$4.5B market-cap company; 9-month $1.2B net income ~27% of market cap, material turnaround. Offset by reliance on one-time risk adjustment gains.

Tradability signal
NO TRADE

No trade: positive news with only +0.6% moved so far — good news prices in within seconds and long-side continuation has shown no measured edge (this cell: -0.53% over 4 hrs, n=325). (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it positive)
before filing · preread
$37.00 ▲ 4.20%
at our read · unknown
$35.51
+10 min · unknown
$36.08 ▲ 1.61%
+30 min · unknown
$36.20 ▲ 1.94%
+1 hr · unknown
$35.30 ▼ 0.59%
+4 hrs · unknown
$34.45 ▼ 2.99%

The stock had already moved -4.03% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ OSCR · stock on Yahoo Finance ↗

See more from November 5, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.